Other Name(s): IGF-1R, IGF-IR, IGF-1 Receptor
Assay:Inhibition of Insulin receptor kinase-beta
Type:IC50
SMILES:CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
Value:=200nM
Source:
Assay:Inhibition of Insulin receptor kinase-beta
Type:IC50
SMILES:CCN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:CC(C)c1cc(/C=C2\C(=O)Nc3ccccc32)cc(C(C)C)c1O
Value:=10100nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:Cc1cccc2c1/C(=C/c1ccc[nH]1)C(=O)N2
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2ccccc2/C1=C/c1ccc[nH]1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2ccc(Br)cc2/C1=C/c1ccc(N2CCOCC2)cc1
Value:>10000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:COc1ccc(/C=C2\C(=O)Nc3ccccc32)cc1C(C)(C)C
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2cc(F)ccc2/C1=C/c1ccc[nH]1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2ccccc2/C1=C/c1n[nH]cc1Cl
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2ccccc2/C1=C/c1ccc(Br)cc1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:CCc1ccc(/C=C2/C(=O)Nc3ccccc32)o1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:Cc1cccc2c1/C(=C/c1ccc(N3CCN(C=O)CC3)cc1)C(=O)N2
Value:=67600nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:CSc1ccc(/C=C2\C(=O)Nc3cccc(C)c32)s1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:Cc1cccc2c1/C(=C/c1ccc(N3CCOCC3)cc1)C(=O)N2
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:CC(C)c1cc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc(C(C)C)c1O
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2ccccc2/C1=C/c1ccc(N2CCOCC2)cc1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:O=C1Nc2ccccc2/C1=C/c1ccc(N2CCCC2)cc1
Value:>100000nM
Source:
Assay:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor
Type:IC50
SMILES:COc1c(Br)cc(/C=C2\C(=O)Nc3ccccc32)cc1C(C)(C)C
Value:>100000nM
Source:

Note: If you'd like to learn how our AI-powered BDE-Chem can help design therapeutic molecules against the IGF1R target, that break through the existing patents, at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai

Molecules for More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BRAF | BRCA1 | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CDKN1A | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA5 | IDO1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SRC | STAT1 | STAT3 | STAT5A | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1